
Mettler-Toledo International Inc
NYSE:MTD

Mettler-Toledo International Inc
Capital Expenditures
Mettler-Toledo International Inc
Capital Expenditures Peer Comparison





Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
Capital Expenditures
$-104.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-2%
|
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
Capital Expenditures
$-1.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-19%
|
![]() |
Danaher Corp
NYSE:DHR
|
Capital Expenditures
$-1.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
![]() |
West Pharmaceutical Services Inc
NYSE:WST
|
Capital Expenditures
$-348.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-9%
|
![]() |
Agilent Technologies Inc
NYSE:A
|
Capital Expenditures
$-284m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
Capital Expenditures
$-660m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-21%
|
Capital Expenditures Growth Mapping
Revenue Scale and Growth Dynamics
See Also
Based on the financial report for Sep 30, 2023, Mettler-Toledo International Inc's Capital Expenditures amounts to -104.9m USD.
Over the last year, the Capital Expenditures growth was 17%. The average annual Capital Expenditures growth rates for Mettler-Toledo International Inc have been -8% over the past three years , 5% over the past five years , and -2% over the past ten years .